Sendai virus N-terminal fusion peptide consists of two similar repeats, both of which contribute to membrane fusion

European Journal of Biochemistry

Volumn 269, Issue 17, 2002, Pages 4342-4350

  Peisajovich, Sergio G ^a   Epand, Raquel F ^b   Epand, Richard M ^b   Shai, Yechiel ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Peptide lipid interactions; Spectroscopic studies; Viral entry

Indexed keywords

PEPTIDE DERIVATIVE; VIRUS FUSION PROTEIN;

ALPHA HELIX; AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; MEMBRANE FUSION; MUTATION; NONHUMAN; NUCLEOTIDE REPEAT; PALMITOYLATION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; SENDAI VIRUS; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; VIRUS ENVELOPE;

CALORIMETRY, DIFFERENTIAL SCANNING; HUMANS; LIPID BILAYERS; LIPOSOMES; MAGNETIC RESONANCE SPECTROSCOPY; MEMBRANE FUSION; MICROSCOPY, ELECTRON; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, SECONDARY; SENDAI VIRUS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL FUSION PROTEINS; VIRUS ASSEMBLY;

RNA VIRUSES; SENDAI VIRUS;

EID: 0036042602     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1033.2002.03132.x     Document Type: Article

References (41)

1. Membrane fusion proteins of enveloped animal viruses
2. Structure of influenza haemagglutinin at the pH of membrane fusion
3. Core structure of gp41 from the HIV envelope glycoprotein
4. Atomic structure of the ectodomain from HIV-1 gp41
5. Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: Conserved helical interactions underlie the broad inhibitory activity of gp41 peptides
6. The crystal structure of the SIV gp41 ectodomain at 1.47 A resolution
7. Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins
8. Structural basis for paramyxovirus-mediated membrane fusion
9. Hydrophobic binding of the ectodomain of influenza hemagglutinin to membranes occurs through the 'fusion peptide'
10. Protein-mediated membrane fusion
11. Membrane fusion by peptide analogues of influenza virus haemagglutinin
12. Studies on the structure of the influenza virus haemagglutinin at the pH of membrane fusion
13. Analyzing the fusion process of influenza hemagglutinin by mutagenesis and molecular modeling
14. Structural characterization of viral fusion proteins
15. A lipid/protein complex hypothesis for exocytotic fusion pore formation
16. Lipid polymorphism and protein-lipid interactions
17. The polar region consecutive to HIV-1 fusion peptide participates in membrane fusion
18. Parainfluenza viruses
19. Paramyxoviridae: The viruses and their replication
20. Trypsin action on the growth of sendai virus in tissue culture cells
21. Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: Putative role during viral fusion
22. 1 protein of paramyxoviruses has two fusion peptides: Implications for the mechanism of membrane fusion
23. Participation of two fusion peptides in measles virus-induced membrane fusion: Emerging similarity with other Paramyxoviruses
24. Sendai virus internal fusion peptide: Structural and functional characterization and a plausible mode of viral entry inhibition
25. The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion
26. Synthesis of the antibacterial peptide cecropin A(1-33)
27. Use of resonance energy transfer to monitor membrane fusion
28. Structure and orientation of the mammalian antibacterial peptide cecropin P1 within phospholipid membranes
29. Determination of protein secondary structure by Fourier transform infrared spectroscopy: A critical assessment
30. Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: Roles of conserved residues in cell fusion
31. Interaction of fluorescently labeled analogues of the amino-terminal fusion peptide of Sendai virus with phospholipid membranes
32. Physiological levels of diacylglycerols in phospholipid membranes induce membrane fusion and stabilize inverted phases
33. Membrane fusion and inverted phases
34. Effect of amphipathic peptides with different alpha-helical contents on liposome-fusion
35. Interaction of the HIV-1 fusion peptide with phospholipid vesicles: Different structural requirements for fusion and leakage
36. On the theory of membrane fusion. The stalk mechanism
37. A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusion
38. 11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes
39. The mechanism of lamellar-to-inverted hexagonal phase transitions in phosphatidylethanolamine: Implications for membrane fusion mechanisms
40. The modified stalk mechanism of lamellar/inverted phase transitions and its implications for membrane fusion
41. The use and misuse of FTIR spectroscopy in the determination of protein structure